AI-designed anti-aging drug rentosertib cuts biological age in Nature study

Insilico Medicine published peer-reviewed results in Nature Biotechnology showing rentosertib, an AI-discovered senolytic, reduced biological age in preclinical models. The claim is based on a single study; human efficacy and safety remain unproven. This marks a notable validation of AI-driven drug discovery for aging, but clinical translation is years away.